![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Szpital Specjalistyczny w Brzozowie, (the Specialist Hospital in Brzozów), Poland, specializes in oncology, hematology and cardiology.
The hospital has 485 beds and electronic hospital records for more than 250,000 patients. Each specialization has its own Primary Investigator and research team and the hospital runs roughly 30 trials per year.
Szpital Specjalistyczny w Brzozowie is the first site in Poland to join Clinerion’s global hospital network. Patient data from the hospital has been live in Clinerion’s Patient Network Explorer since December, 2018.
The hospital is also the first site to connect to Patient Network Explorer using an API developed by Asseco, the provider of Szpital Specjalistyczny w Brzozowie’s hospital information system. This API will simplify Patient Network Explorer’s data integration with hospitals using Asseco systems, in future. The data integration with Szpital Specjalistyczny w Brzozowie also uses machine learning technologies developed by Clinerion to extract and structure laboratory values available from free text.
“Patient Network Explorer helps us get more clinical trials, as well as makes patient recruitment more effective and efficient,” says Tomasz Kondraciuk, Director of Szpital Specjalistyczny w Brzozowie. “Daily automated notifications about new potential candidates in the Patient Network Explorer’s “Patient Finder” tool help a lot to enroll more patients in our clinical trials.”
“Szpital Specjalistyczny w Brzozowie is a world-class hospital and clinical trials facility. We are pleased to support them in gaining international exposure and participation in the most cutting-edge international research,” says Ian Rentsch, CEO of Clinerion.
About Clinerion
Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland. Clinerion website: www.clinerion.com
About Szpital Specjalistyczny w Brzozowie
Szpital Specjalistyczny w Brzozowie is a full-profile hospital specializing in oncology and hematology. Broad spectrum of medical specialisations delivered by our medical professionals allow to offer complex diagnostic and therapeutic treatment to our patients. Cancer patients benefit from access to most current medical technologies, including surgery, radiotherapy, brachytherapy and clinical oncology. The hospital runs all oncology medicine access programmes reimbursed in Poland, as well as offers access to a number of phase II – IV clinical trials.
